Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Org Chem ; 83(1): 510-515, 2018 01 05.
Artigo em Inglês | MEDLINE | ID: mdl-29227094

RESUMO

The [2,1-a]- and [1,2-a]-isomers of fluorenofluorenedione have been synthesized via intramolecular Friedel-Crafts acylations. DFT calculations indicate that the [1,2-a]-isomer adopts a twisted, helical C2-symmetric structure and that its protonated form is the thermodynamic product of the Friedel-Crafts acylation in hot sulfuric acid. Absorption spectroscopy and cyclic voltammetry measurements provide experimental estimations of frontier molecular orbital energy levels, which are reported and discussed.

2.
Med Care ; 55(12): 993-1000, 2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29036012

RESUMO

BACKGROUND: Disparities in the presentation of knee osteoarthritis (OA) and in the utilization of treatment across sex, racial, and ethnic groups in the United States are well documented. OBJECTIVES: We used a Markov model to calculate lifetime costs of knee OA treatment. We then used the model results to compute costs of disparities in treatment by race, ethnicity, sex, and socioeconomic status. RESEARCH DESIGN: We used the literature to construct a Markov Model of knee OA and publicly available data to create the model parameters and patient populations of interest. An expert panel of physicians, who treated a large number of patients with knee OA, constructed treatment pathways. Direct costs were based on the literature and indirect costs were derived from the Medical Expenditure Panel Survey. RESULTS: We found that failing to obtain effective treatment increased costs and limited benefits for all groups. Delaying treatment imposed a greater cost across all groups and decreased benefits. Lost income because of lower labor market productivity comprised a substantial proportion of the lifetime costs of knee OA. Population simulations demonstrated that as the diversity of the US population increases, the societal costs of racial and ethnic disparities in treatment utilization for knee OA will increase. CONCLUSIONS: Our results show that disparities in treatment of knee OA are costly. All stakeholders involved in treatment decisions for knee OA patients should consider costs associated with delaying and forgoing treatment, especially for disadvantaged populations. Such decisions may lead to higher costs and worse health outcomes.


Assuntos
Artroplastia do Joelho/economia , Disparidades em Assistência à Saúde/economia , Modelos Econômicos , Osteoartrite do Joelho/economia , Artroplastia do Joelho/estatística & dados numéricos , Análise Custo-Benefício , Feminino , Custos de Cuidados de Saúde , Necessidades e Demandas de Serviços de Saúde/economia , Disparidades nos Níveis de Saúde , Humanos , Masculino , Osteoartrite do Joelho/epidemiologia , Estados Unidos
3.
J Vet Intern Med ; 34(4): 1379-1388, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32501601

RESUMO

BACKGROUND: The clinical relevance of echocardiographic measurements of right heart size and function in dogs with pulmonary hypertension (PH) is unknown. OBJECTIVE: To determine if echocardiographic measurements of right heart size and right ventricular (RV) function are associated with survival times in dogs with PH. ANIMALS: Eighty-two client-owned dogs. METHODS: Retrospective study where data from medical records and baseline echocardiographic examinations were collected and measured in a standardized manner. Owners or primary veterinarians were contacted for outcome data. RESULTS: Enlargement of the right atrium (88%), RV (69%), and pulmonary artery (72%) was common. One-third of the cases had reduced RV function quantified by two-dimensional echocardiography-derived tricuspid annular plane systolic excursion (TAPSE). Decreased TAPSE was significantly (P = .008) more common in dogs with PH not secondary to left heart disease (LHD; 43%) compared to dogs with PH secondary to LHD (14%) but median survival times (182, 95% confidence interval [CI] = 39-309 versus 298, 95% CI = 85-314 days, respectively) were not significantly different (P = .78). Right atrial area (hazard ratio [HR] = 2.72, 95% CI = 1.58-4.70), TAPSE < 3.23 mm/kg0.284 (HR = 2.19, 95% CI = 1.28-3.74), and right heart failure (HR = 2.05, 95% CI = 1.18-3.57) were independently associated with shorter survival time (P ≤ .04). CONCLUSIONS AND CLINICAL IMPORTANCE: Right atrial area, RV function (TAPSE < 3.23 mm/kg0.284 ), and right heart failure offer clinically relevant prognostic information in dogs with PH. Results support the quantitative assessment of right heart size and function in dogs with PH.


Assuntos
Doenças do Cão/diagnóstico por imagem , Ecocardiografia/veterinária , Hipertensão Pulmonar/veterinária , Disfunção Ventricular Direita/veterinária , Animais , Doenças do Cão/fisiopatologia , Cães , Feminino , Coração/diagnóstico por imagem , Insuficiência Cardíaca/veterinária , Hipertensão Pulmonar/complicações , Hipertensão Pulmonar/diagnóstico por imagem , Masculino , Prognóstico , Estudos Retrospectivos , Valva Tricúspide/diagnóstico por imagem , Valva Tricúspide/fisiopatologia , Disfunção Ventricular Direita/fisiopatologia
4.
Arthritis Care Res (Hoboken) ; 72(5): 692-698, 2020 05.
Artigo em Inglês | MEDLINE | ID: mdl-30980467

RESUMO

OBJECTIVE: The present study was undertaken to investigate whether Latina and African American women with arthritis-related knee pain and primary care providers who treat them believe their treatment decisions would benefit from having more information about the impact of treatment on their quality of life, medical care costs, and work productivity. METHODS: We conducted 4 focus groups of Latina and African American women over age 45 years who had knee pain. We also conducted 2 focus groups with primary care providers who treated Latina and African American women for knee pain. The participants were recruited from the community. They were asked their opinions about a decision tool that presented information on a range of treatment options and their impacts on quality of life, medical care costs, and work productivity. They were asked whether providing this information would help them make better treatment decisions. We analyzed the focus group transcripts using ATLAS.ti. RESULTS: We found that minority women and primary care providers endorsed the use of a decision-making tool that provided information of the impact of treatment on quality of life, medical care costs, and work productivity. Providers felt that patients would benefit from having the additional information but were concerned about its complexity and some patients' ability to comprehend the information. CONCLUSION: Latina and African American women could make more informed treatment decisions for their knee pain using a decision-making tool that provides them with significant information about how various treatment options may impact their quality of life, medical care costs, and workforce productivity.


Assuntos
Artralgia/economia , Artralgia/terapia , Negro ou Afro-Americano/psicologia , Tomada de Decisão Clínica , Custos de Cuidados de Saúde , Conhecimentos, Atitudes e Prática em Saúde/etnologia , Hispânico ou Latino/psicologia , Osteoartrite do Joelho/economia , Osteoartrite do Joelho/terapia , Médicos de Atenção Primária/psicologia , Qualidade de Vida , Artralgia/etnologia , Artralgia/psicologia , Atitude do Pessoal de Saúde , Comportamento de Escolha , Análise Custo-Benefício , Assistência à Saúde Culturalmente Competente/etnologia , Técnicas de Apoio para a Decisão , Emprego , Feminino , Grupos Focais , Humanos , Pessoa de Meia-Idade , Osteoartrite do Joelho/etnologia , Osteoartrite do Joelho/psicologia , Seleção de Pacientes , Atenção Primária à Saúde , Fatores Raciais , Recuperação de Função Fisiológica , Resultado do Tratamento
5.
Chem Commun (Camb) ; 55(94): 14186-14189, 2019 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-31701965

RESUMO

Fluoreno[2,1-a]fluorene, a molecule comprising fused ortho-quinodimethane units in a 1,5-napthoquinodimethane core, has been prepared and investigated with spectroscopy (UV-Vis-NIR, 1H-NMR and Raman), SQUID magnetometry, spectroelectrochemistry and quantum chemistry. While para-quinodimethanes with a 2,6-substitution pattern exist as closed-shell species and meta-quinodimethanes with 2,7-substitution favour a ground electronic state with very large diradical character, our 1,5-substituted ortho-naphthoquinodimethane-based system exhibits an intermediate degree of diradical character.

6.
Am J Med Sci ; 327(1): 5-8, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14722389

RESUMO

BACKGROUND: Amphotericin B is used commonly to treat fungal infections. Unfortunately, little information exists regarding the use of intravenous amphotericin B in patients with end-stage renal disease (ESRD). METHODS: We retrospectively reviewed the clinical course of patients receiving amphotericin B during hemodialysis (HD). Twenty-five episodes of systemic fungal infection occurring in 24 patients with ESRD treated with parenteral amphotericin B administered during HD were noted. Patients received a maintenance dose of 0.5 to 1.0 mg/kg amphotericin B intravenously thrice weekly during HD sessions. Twenty-three patients received either 500 or 1000 mg of amphotericin B, whereas 1 patient with AIDS received a total of 6,500 mg. RESULTS: Intradialytic hypotension developed in 27.7% of HD sessions during treatment with amphotericin B compared with 28.8% of 20 HD sessions evaluated before initiation of amphotericin B therapy. Four patients exhibited a temperature rise greater than 38.8 degrees C during drug infusion (1 episode per patient). Increases in heart rate and ventricular ectopy were rare. Serum potassium concentrations as well as Kt/V and urea reduction ratio did not change significantly. All patients (except the patient with AIDS) resolved their respective fungal infections. CONCLUSIONS: Intradialytic administration of amphotericin B was generally well tolerated. Our observations suggest that amphotericin B is effective and safe for outpatient intradialytic therapy when administered according to protocol.


Assuntos
Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Soluções para Hemodiálise/administração & dosagem , Falência Renal Crônica/complicações , Micoses/tratamento farmacológico , Adolescente , Adulto , Idoso , Anfotericina B/efeitos adversos , Anfotericina B/uso terapêutico , Antifúngicos/efeitos adversos , Antifúngicos/uso terapêutico , Soluções para Hemodiálise/efeitos adversos , Soluções para Hemodiálise/uso terapêutico , Humanos , Pessoa de Meia-Idade , Micoses/etiologia , Diálise Renal/efeitos adversos , Estudos Retrospectivos , Resultado do Tratamento
7.
J Emerg Med ; 25(2): 163-6, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12902002

RESUMO

A 31-year-old man ingested 400 mg of citalopram (Celexa) after an argument with his parents and girlfriend 13 h before presentation. Paramedics witnessed the patient having a generalized clonic seizure. The electrocardiogram (EKG) revealed a wide QRS complex, prolongation of the QTc interval, and left bundle branch pattern. He was treated with sodium bicarbonate with resolution of these changes. The patient was continued on a sodium bicarbonate infusion and demonstrated no further EKG abnormalities. Sodium bicarbonate should be considered as a treatment modality in patients with EKG abnormalities of prolongation of QRS or QTc interval after citalopram overdose.


Assuntos
Citalopram/intoxicação , Convulsões/induzido quimicamente , Inibidores Seletivos de Recaptação de Serotonina/intoxicação , Adulto , Overdose de Drogas , Eletrocardiografia , Humanos , Masculino , Bicarbonato de Sódio/administração & dosagem
8.
J Long Term Eff Med Implants ; 24(2-3): 195-204, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25272218

RESUMO

The factors that contribute to musculoskeletal healthcare disparities may influence the results of studies regarding the long-term outcome of orthopaedic implants. Patient decisions regarding their healthcare and their subsequent outcomes are influenced by health literacy. Providing patients with the information that they need to consent to treatment must be provided in a culturally competent manner. The influence of the physician or healthcare provider on the treatment choice varies depending on the type of decision-making process: patient-based, physician-based, or shared decision making. Respecting the patient's autonomy while acknowledging the knowledge and experience of the physician, we advocate for shared decision making. This may require modification of existing regulations regarding informed consent. Furthermore, federal and state directives have been put into place to address healthcare disparities, especially with respect to culturally competent care and access to proper healthcare.


Assuntos
Competência Cultural , Tomada de Decisões , Letramento em Saúde , Disparidades em Assistência à Saúde , Consentimento Livre e Esclarecido , Doenças Musculoesqueléticas/terapia , Acessibilidade aos Serviços de Saúde , Humanos , Participação do Paciente , Patient Protection and Affordable Care Act/legislação & jurisprudência , Autonomia Pessoal
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA